AEB Group, a worldwide leader in biotechnological ingredients for wine, food and beverage.
Paris, 21 September 2018 – As announced in our press release dated 5 September, a new transaction has been signed by Apax Partners SAS: the acquisition from SK Capital of 100% of the Italian company AEB Group, a worldwide leader in biotechnological ingredients and related services for wine, food and beverage. The company’s management will reinvest alongside Apax Funds.
Leveraging their expertise in biotechnology and oenology, AEB Group offers custom solutions based on more than 600 proprietary products and specialty equipment, especially designed for the wine, beer, juice, cider and food industry.
With a unique coverage across 5 continents, AEB Group employs more than 300 persons, including 170 agents and sales representatives in 13 countries. The company has 8 production units, 4 R&D laboratories and 7 quality control laboratories globally and collaborates with more than 20 universities and research institutes to foster continuous innovation. In 2017, the company generated revenues of nearly €100 million.
The company’s objective is to pursue its international expansion by leveraging the existing worldwide sales and agents network and to conduct an ambitious buy and build strategy.
Financial terms of the transaction are not disclosed. Closing of the transaction is expected in the beginning of October.
Altamir’s investment is expected to be in the region of €35m based on the upper limit of its commitment in the Apax France IX fund.
About Altamir
Altamir is a listed private equity company (Euronext Paris-B, ticker: LTA) founded in 1995 and with almost €800m in assets under management. Its objective is to provide shareholders with long term capital appreciation and regular dividends by investing in a diversified portfolio of private equity investments.
Altamir’s investment policy is to invest via and with the funds managed by Apax Partners SAS and Apax Partners LLP, two leading private equity firms that take majority or lead positions in buyouts and growth capital transactions and seek ambitious value creation objectives.
In this way, Altamir provides access to a diversified portfolio of fast-growing companies across Apax’s sectors of specialisation (TMT, Consumer, Healthcare, Services) and in complementary market segments (mid-sized companies in French-speaking European countries and larger companies across Europe, North America and key emerging markets).
Altamir derives certain tax benefits from its status as an SCR (“Société de Capital Risque”). As such, Altamir is exempt from corporate tax and the company’s investors may benefit from tax exemptions, subject to specific holding-period and dividend-reinvestment conditions.
For more information: www.altamir.fr
Contact
Agathe Heinrich
Tel: +33 1 53 65 01 74
E-mail: investors@altamir.fr
